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Abstract 
Purpose: To report the case of a young patient affected by neurofibromatosis 1 (NF-1) with 
peripheral retinal ischemia-induced neovascular glaucoma and the peculiar spectral-domain 
optical coherence tomography (SD-OCT) features. Material and Methods: A 13-year-old boy 
affected by NF-1, as diagnosed according to established criteria, was referred with a 
diagnosis of hypertensive uveitis in his left eye. He underwent a complete ophthalmic 
examination and comprehensive blood work with viral and immunological tests. The case 
was documented with fluorescein angiography (FA) and SD-OCT. When the intraocular 
pressure (IOP) of the left eye decreased and the cornea cleared, FA revealed retinal ischemia 
and leakage from pathologic retinal vessels. SD-OCT revealed foveal hypoplasia secondary to 
the complete absence of the retinal nerve fiber layer. Results: Peripheral retinal ischemia-
induced neovascular glaucoma was diagnosed. The patient underwent Ahmed valve 
implantation to control his IOP, and subsequent retinal photocoagulation by argon laser and 
intravitreal bevacizumab injection were performed to control neovascularization. Discussion: 
Retinal ischemia in NF-1 might lead to neovascular glaucoma: lowering of the IOP with 
surgical implantation of an Ahmed valve, regression of neovascularization by argon laser 
panretinal photocoagulation and intravitreal injection of bevacizumab can be a helpful way 
to control such a complication. 
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Introduction 
Neurofibromatosis type 1 (NF-1) is a hereditary disease with systemic vascular ischemic 
manifestations described in the aorta, brain, kidney and also the eye. Other ocular manifesta-
tions in NF-1 are plexiform neurofibromas of the eyelids, Lisch nodules of the iris, congenital 
glaucoma, optic glioma, retinal astrocytic hamartomas, retinal capillary hemangiomas and 
microvascular retinal abnormalities [1]. Different vascular retinal abnormalities have been 
described in NF-1 such as stenosis of small vessels, progressive capillary ischemia and 
compensatory collateral circulation [2]. 
We report the case of a 13-year-old boy, affected by NF-1, with a diagnosis of peripheral 
retinal ischemia-induced neovascular glaucoma and the peculiar spectral-domain optical 
coherence tomography (SD-OCT) features. 
Material and Methods 
A 13-year-old boy affected by NF-1 was referred to our Eye Clinic in January 2011 due to 
a 1-month history of pain, redness and blurred vision in his left eye, which had been 
previously diagnosed and treated as hypertensive uveitis. The diagnosis of NF-1 was made in 
childhood according to established criteria: he had multiple café au lait spots, plexiform 
neurofibromas of the neck, trunk and limbs, and Lisch nodules of the iris in both eyes. He 
had no first-degree relatives affected by NF-1. 
At our clinic, his best-corrected visual acuity was 20/20 in his right eye and light percep-
tion in the left eye. Slit lamp examination in the left eye showed diffuse corneal edema, 
conjunctival hyperemia and normal anterior chamber depth with pupil mydriasis. No other 
iris features were visible at that moment nor was the fundus aspect. The intraocular 
pressure (IOP) was 16 mm Hg in the right eye and 45 mm Hg in the left eye, by Goldmann 
applanation tonometry, under maximal medical therapy (acetazolamide 250 mg per os 3 
times a day, topical medications such as timolol maleate-dorzolamide fixed combination and 
topical steroids such as dexamethasone eye drops 6 times a day to control intraocular 
inflammation). 
Results 
The patient was admitted, and therapy was initiated with intravenous mannitol 500 ml 
twice a day plus maximal topical medications to lower his IOP. The following day, slit lamp 
examination revealed a clear cornea with iris neovascularization. The IOP was 10 mm Hg in 
the right eye and 32 mm Hg in the left eye. Fundus examination of the left eye was now 
possible and showed optic atrophy and vitreous haze; diffuse retinal vascular changes 
included dilated and tortuous veins, narrowing of the retinal arterioles and arteriovenous 
communications. 
We performed fluorescein angiography (FA) and SD-OCT using the Heidelberg Spectra-
lis HRA-OCT. FA revealed retinal ischemia and peripheral leakage from pathological retinal 
vessels and vitreous hemorrhage (fig. 1). SD-OCT of the macula revealed the complete 
absence of the retinal nerve fiber layer in the posterior pole, and, consequently, no foveal 
depression was present (fig. 2). Blood biochemistry tests, blood count, erythrocyte 
sedimentation rate and viral and immunological tests yielded normal results. 
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In the end, peripheral retinal ischemia-induced neovascular glaucoma in the left eye was 
diagnosed. The IOP remained over 40 mm Hg for 3 days even with intravenous mannitol 500 
ml twice a day and topical medications to lower his IOP. Because of the failure of medical 
therapy, he underwent Ahmed valve implantation to control the IOP. On the first postopera-
tive day, the IOP was 28 mm Hg in the left eye. 
Two weeks after surgery, retinal photocoagulation by argon laser and intravitreal 
bevacizumab injection under general anesthesia were performed. The final best-corrected 
visual acuity was count fingers, and the IOP was 26 mm Hg in the left eye. No pain or 
discomfort was reported. We discharged the patient with timolol maleate-dorzolamide fixed 
combination twice a day. 
One month later, FA and SD-OCT were performed. FA revealed no leakage or other 
retinal vessel abnormalities, and SD-OCT remained unchanged. Slit lamp examination 
showed a clear cornea, with the tube well positioned in the anterior chamber (fig. 3), 
complete regression of rubeosis and pupil midriasis. The IOP was 22 mm Hg by Goldmann 
applanation tonometry. 
Discussion 
Systemic vascular occlusive disease has been previously reported in NF-1 to affect aor-
tic, cerebral, renal, celiac and mesenteric vessels. The pathogenic hypothesis in this case was 
related to the growth of Schwann cells and dysplasia of arteriolar smooth muscle cells, which 
led to a progressive narrowing of the vessel and consequent occlusion with secondary 
fibrous changes [3]. 
Elgi et al. [4] proposed the hyperproliferation of pericytes and endothelial cells as the 
cause of retinal vascular occlusion and neovascularization in NF-1. In chronic and slowly 
progressive arteriolar inadequacy, the veins might not suffer from arterial narrowing in an 
early phase; in a young patient, progressive occlusion may be due to a more compensative 
venous system [5]. However, a chronic reduction of arterial supply can lead to progressive 
retinal ischemia [6]. 
Ozerdem [7] published a paper about NF-1 gene mutations as a cause of increased pro-
liferation of pericytes and endothelial cells that might enhance the angiogenic response of 
the retina to the ischemia. Moreover, loss of neurofibromin expression in endothelial cells 
could affect the interactions between endothelial cells and pericytes with a consequently 
abnormal proliferation of both these cells and final vascular occlusion. Elgi et al. [4] reported 
a case very similar to ours, emphasizing the unilateral appearance of the disease. The 
mechanism of this unilaterality, which we observed as well, is not fully understood but is 
reported in other organs too, such as the kidney, brain and large vessels of the heart; it is 
recognized as a characteristic feature of ischemia in NF-1. Furthermore, we postulate that in 
our patient arteriolar occlusion associated with microvascular alterations and peripheral 
retinal ischemia could be the cause of neovascular glaucoma, even if the angiogram did not 
register arteriovenous communication between perfused and nonperfused retinas. A 
vitreous opacity previously noted by Elgi et al. [4] was supposedly the aftermath of a 
vitreous hemorrhage. 
One characteristic feature of the SD-OCT was the absence of the foveal depression, 
which we related to a glaucomatous optic nerve and complete atrophy of the retinal nerve 
fiber layer. As has been previously reported, we also associated the use of intravitreal 
bevacizumab and argon laser panretinal photocoagulation with better control of neovascu-
larization. 
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Fig. 1. Composite FA, left eye. The optic nerve head is atrophic and hypofluorescent. In the peripheral 
retina, significant leakage from pathological vessels and ischemia are evident. 
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Fig. 2. OCT demonstrates the complete absence of the retinal nerve fiber layer in the macula and, 
consequently, no foveal depression. 
 
 
 
Fig. 3. One month after surgery the cornea is clear, no rubeosis can be seen and the tube is well 
positioned in the anterior chamber. 
 
